JNJ

Johnson & Johnson
D

JNJ

154.020
USD
2.14
(1.41%)
Market Closed
Volume
451,175
EPS
0
Div Yield
0
P/E
23
Market Cap
370,763,669,591
Signals
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    165.02 USD
    ABT
    ABT
    0.850
    (0.74%)
    115.9 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    283.72 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    745.89 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    96.29 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.07 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    24.8 USD
    SYK
    SYK
    6.90
    (1.80%)
    390.18 USD
    More
News

Title: Johnson & Johnson

Sector: Healthcare
Industry: Drug Manufacturers - General
Johnson & Johnson is an American multinational corporation founded in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. The company’s ethos is centered around good health as the foundation of vibrant lives. Since its inception, it has continued this mission and is now considered the world’s largest and most broadly based healthcare company, with more than 140,000 employees around the world. The company develops medical devices, pharmaceuticals, and consumer packaged goods. It features prominently in the top 50 of the Fortune 500 list of corporations by total revenue. The company is headquartered in New Brunswick, New Jersey. Its holdings include some 250 subsidiary companies with operations in 60 countries and products sold in over 175 nations. Among its best-known brand assets are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin products, and more.